Breathe Well Live Well
MedPage Today |
Asthma Treatment Before School Cuts Exacerbations
MedPage Today Inner city children with asthma had fewer exacerbations when pretreated prior to the start of school, according to a randomized clinical trial. The trial, published in The Journal of Allergy and Clinical Immunology, found that adding omalizumab to … |
View full post on asthma – Google News
ABC Online |
Tasmanian researchers scrutinise athletes' use of asthma treatment as …
ABC Online The World Anti-Doping Agency (WADA) is funding research at the University of Tasmania to improve the testing regime for a common asthma drug suspected of enhancing athletic performance. Dr Glenn Jacobson from the University of Tasmania's School of … |
View full post on asthma – Google News
|
Study compares LRTAs with placebo for the treatment of asthma
Pharmacy Today, American Pharmacists Association, pharmacist.com Researchers conducted a systematic review and meta-analysis to compare leukotriene-receptor antagonists (LTRAs) with placebo in patients with mild asthma. The review, funded by NIH, included 50 randomized trials conducted through June 2015. |
View full post on asthma – Google News
Medscape |
Asthma: No Clear Winners in Combination Treatment in Blacks
Medscape Long-acting anticholinergic agents may be a reasonable substitute for long-acting beta-agonists (LABAs) in combination with inhaled corticosteroids (ICS) for asthma in black adults, according to the findings of a clinical efficacy trial comparing both … |
View full post on asthma – Google News
|
Nebulizers, Inhalers and Respirators for Asthma Treatment Market: PMR's …
Medgadget.com (blog) logo346 Asthma is a chronic inflammatory lung disease which affects persons across all ages. It creates inflammation inside the walls of airways, causing airways to narrow, swell and produce extra mucous. It is caused due to genetic factors or … |
View full post on asthma – Google News
Condition: DeQuervain Tendinopathy
Interventions: Drug: Celestone; Drug: Ketorolac
Sponsor: OrthoCarolina Research Institute, Inc.
Recruiting – verified November 2015
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
MD Magazine |
Children with asthma fare better with specialized treatment from allergists
Clinical Advisor Children with asthma who are treated by an allergist are less likely to end up in the emergency department with an asthma attack, according to research presented at the American College of Allergy, Asthma, and Immunology (ACAAI) Annual Scientific … Adherence to Omalizumab Does Not Correlate with Better Response for Asthma Study questions benefit of breastfeeding in preventing allergies, asthma Adverse Reaction to Aspirin Often Misdiagnosed as Allergy |
View full post on asthma – Google News
Ledger Gazette |
FDA approves Mepolizumab for maintenance treatment of severe asthma
Ledger Gazette The US Food and Drug Administration has cleared use of Nucala (mepolizumab) in patients with severe asthma aged 12 years and older whose condition is driven by eosinophilic inflammation, offering patients access to the first and only approved biologic … Nucala approved to treat severe asthma |
View full post on asthma – Google News
Conditions: Allergy; Asthma; Rhinitis
Interventions: Drug: Mitizax; Drug: Placebo
Sponsors: Abbott; Linical Co., Ltd; Datamap
Recruiting – verified November 2015
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
International Business Times |
Glaxo's Injectable Asthma Treatment 'Nucala' Gets Approval From FDA
International Business Times The U.S. Food and Drug Administration (FDA) has given a go ahead to GlaxoSmithKline Plc's drug Nucala for treatment of severe asthma. The regulato6ry body said that the drug can be used in combination with other therapies and medications for asthma … FDA Approves New Asthma Medication Mepolizumab gets green signal from FDA to be used for maintenance treatment of … GlaxoSmithKline plc (ADR): Why Nucala's FDA Approval Is Significant |
View full post on asthma – Google News